Information technology is transforming healthcare before our eyes, and in just a few years, the industry will be unrecognizable. To address this timely topic, the Mayes College of Healthcare Business and Policy at University of the Sciences in Philadelphia
is proud to present a unique forum for policy dialogue on the Future of Health Information Technology on May 14, 2009, from 5-7 p.m. at the McNeil Science and Technology Center
The health policy symposium, organized by Mayes College’s Department of Health Policy and Public Health, brings together a panel of prominent experts with experience in industry, government, academia, and medicine who will seek to define a vision for digital healthcare. In doing so, they will frame an agenda for understanding this emerging technology that has the potential to bring tremendous strides in patient care and population health but also new threats to patient privacy and new opportunities for external intrusions into clinical practice.
“Everyone who is working to shape the future of healthcare, from President Obama to physicians at bedsides, agrees that information technology is the key,” said Dr. Robert I. Field, chair of the department and organizer of the symposium. “It is revolutionizing care at all levels, and is seen as a panacea for a range of health system ailments, such as high costs, poor care coordination, and medical errors. But what, exactly, will computerized healthcare look like? That is what the experts on the symposium panel will help us to understand.”
The forum, which will be moderated by Dr. Carolyn M. Clancy, director of the Agency for Healthcare Research and Quality, features Dr. Richard J. Baron, chair of the American Board of Internal Medicine and a physician with Greenhouse Internists; Dr. Joseph F. Coughlin, director of the Massachusetts Institute of Technology AgeLab; and Dr. Lawrence L. Weed, founder of Problem Knowledge Couplers Corp.
The free-ranging discussion, guided by audience questions, will focus the collective knowledge and experience of these experts on defining key issues, exploring paths to solutions, and gaining a vision of the brave new world to come. The symposium is made possible by an unrestricted educational grant from AstraZeneca Pharmaceuticals.